Globus Medical, Inc. announced the resignation of chief executive officer, Dave Demski, after nearly 20 years with the company, with the last four and a half years as its CEO. The board of directors has named Daniel T. Scavilla as the company's chief executive officer, effective immediately.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
66.78 USD | +0.96% | +0.54% | +25.11% |
05-29 | BTIG Adjusts Globus Medical's Price Target to $72 From $63, Keeps Buy Rating | MT |
05-20 | Piper Sandler Upgrades Globus Medical to Overweight From Neutral, Adjusts Price Target to $80 From $60 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.11% | 8.93B | |
-4.60% | 184B | |
+0.06% | 107B | |
-3.89% | 67.9B | |
-5.60% | 46.49B | |
+11.56% | 45.81B | |
+6.38% | 42.55B | |
+19.05% | 30.78B | |
+16.53% | 26.11B | |
-5.00% | 23.9B |
- Stock Market
- Equities
- GMED Stock
- News Globus Medical, Inc.
- Globus Medical, Inc. Announces Executive Changes